Please login to the form below

Not currently logged in
Email:
Password:

S-A launches £50,000 patient group bursary

Sanofi-aventis has strengthened its support for patient groups in the UK with the launch of a new patient group bursary

Sanofi-aventis (S-A) has strengthened its support for patient groups in the UK with the launch of a new £50,000 patient group bursary.

With the NHS in England set to undergo major structural and cultural change through the implementation of the government's far-reaching healthcare plans, S-A said it believes that patient groups will have a more important role in championing the needs of individual patients and improving the quality of their care.

The patient group bursary scheme invites applications from all patient groups, including local groups, social enterprises or professional associations proposing projects in three key categories:

• Developing capacity to deliver health services to the NHS
• Improving and promoting patient empowerment and information
• Reducing health inequalities.

As part of the 2011 scheme, two groups will be awarded grants of £25,000 each to support new programmes in the above areas running throughout the year.

Announcing the new scheme, S-A UK general manager, Steve Oldfield, said: "This is an exciting development that reaffirms our commitment to working in partnership with patient groups to meet the needs of professionals and patients in the NHS alike."

A panel of judges, chaired by Steve Oldfield and including the Liberal Democrat Peer and former chief executive of the King's Fund, Baroness Julia Neuberger, and Baroness Jill Pitkeathley, chair of the Council of Healthcare Regulatory Excellence (CHRE), will meet to assess applications and decide the winning programmes in May.

Applications for the scheme will close on April 20, 2011.

S-A has more informaiton on how to apply for the bursary.

The winning programmes will be announced in May.

29th March 2011

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics